70/100BFerguson stock forecast 2027–2032What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Ferguson is 283.10, 10.2% above the current price of 256.85. Their targets range from 252.00 to 325.00.
Of the 13 firms that rated Ferguson in the past 12 months, 10 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 252.00 to 325.00, with an average of 283.10.
| Buy | 10 | |
| Hold | 3 | |
| Sell | 0 |
12-month price target
| Highest target | 325.00 |
| Average target | 283.10 |
| Lowest target | 252.00 |
| Current price | 256.85 |
Ferguson price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Ferguson price target and rating?
How analysts rate Ferguson, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
10 of 13 firms rate it buy now, against 10 of 13 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Ferguson analyst upgrades, downgrades and price targets
The latest rating change came on 27 October 2026, when Citigroup upgraded Ferguson from Neutral to Buy. The most recent new target came from RBC Capital on 10 November 2026: 288.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 10 Nov 2026 | RBC Capital Mike Dahl | — | 286.00 → 288.00 | +0.7% | 254.09 |
| 27 Oct 2026 | Citigroup | Upgraded · Neutral → Buy | — | — | — |
| 7 Oct 2026 | RBC Capital | Reiterated · Outperform | 290.00 → 286.00 | -1.4% | 217.49 |
| 6 Oct 2026 | Melius Research | — | 252.00 | — | 222.93 |
| 3 Sept 2026 | Jefferies | — | 300.00 → 295.00 | -1.7% | 223.23 |
| 18 Aug 2026 | Deutsche Bank | — | 246.00 → 261.00 | +6.1% | 242.62 |
| 11 Aug 2026 | RBC Capital | Reiterated · Outperform | 281.00 → 290.00 | +3.2% | 253.76 |
| 11 Aug 2026 | UBS | Reiterated · Neutral | 220.00 → 256.00 | +16.4% | 259.61 |
| 11 Aug 2026 | Oppenheimer | Reiterated · Outperform | 288.00 | — | 263.78 |
| 11 Aug 2026 | Bernstein Connor Cerniglia | Reiterated · Outperform | 288.00 → 325.00 | +12.8% | 253.78 |
| 11 Aug 2026 | Robert W. Baird | — | 265.00 → 288.00 | +8.7% | 263.78 |
| 11 Aug 2026 | Barclays Matthew Bouley | Reiterated · Overweight | 297.00 → 313.00 | +5.4% | 263.78 |
| 17 Jul 2026 | Zelman & Assoc | Upgraded · Neutral → Outperform | — | — | — |
| 7 Jul 2026 | Goldman Sachs | Downgraded · Buy → Neutral | — | — | — |
| 6 Jul 2026 | Goldman Sachs Suhasini Varanasi | — | 265.00 | — | 228.92 |
| 8 May 2026 | Barclays | Reiterated · Overweight | 278.00 → 297.00 | +6.8% | 246.53 |
| 6 May 2026 | RBC Capital | Reiterated · Outperform | 271.00 → 281.00 | +3.7% | 255.36 |
| 25 Feb 2026 | Truist Financial | — | 300.00 | — | 258.03 |
| 24 Feb 2026 | Jefferies Philip Ng | — | 289.00 → 300.00 | +3.8% | 261.85 |
| 24 Feb 2026 | RBC Capital Mike Dahl | — | 247.00 → 271.00 | +9.7% | 261.79 |
| 15 Jan 2026 | Barclays Matthew Bouley | Reiterated · Overweight | 267.00 → 278.00 | +4.1% | 246.10 |
| 9 Jan 2026 | RBC Capital Mike Dahl | — | 243.00 → 247.00 | +1.6% | 229.42 |
| 11 Dec 2025 | Deutsche Bank | Reiterated · Hold | 246.00 | — | 229.81 |
| 10 Dec 2025 | RBC Capital Mike Dahl | — | 189.00 → 243.00 | +28.6% | 230.11 |
| 10 Dec 2025 | UBS John Lovallo | Reiterated · Neutral | 225.00 → 220.00 | -2.2% | 226.02 |
| 10 Dec 2025 | Robert W. Baird David Manthey | — | 262.00 → 265.00 | +1.1% | 226.02 |
| 10 Dec 2025 | Bernstein Connor Cerniglia | — | 288.00 | — | 226.02 |
| 10 Dec 2025 | Barclays Matthew Bouley | Reiterated · Overweight | 273.00 → 267.00 | -2.2% | 226.02 |
| 2 Dec 2025 | Jefferies | Reiterated · Buy | 289.00 | — | 251.54 |
Ferguson EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Ferguson's EPS to grow 14.3% a year until 2028. Over the last 5 years it grew 17.1% a year, and over the last 3 years it fell 1.3%.
Analysts expect Ferguson's revenue to grow 6.5% a year until 2028. Over the last 5 years it grew 9.1% a year, and over the last 3 years 2.5%.
Revenue
EPS
Does Ferguson beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 6.3% off the result, either way, and their revenue estimate 1.8%, over the last 12 quarters.
- EPS beats
- 14 / 22
- Revenue beats
- 14 / 21
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +3.5%
- Since
- March 2021
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 9 Nov 2026 | 3.31 | 3.43 | +3.6% | 8.74B | 9.03B | +3.3% |
| Q4 FY2026 | 10 Aug 2026 | 3.31 | 3.39 | +2.4% | 8.69B | 8.75B | +0.8% |
| Q3 FY2026 | 5 May 2026 | 2.16 | 2.28 | +5.6% | 7.41B | 7.47B | +0.8% |
| Q2 FY2026 | 24 Feb 2026 | 3.48 | 3.43 | -1.4% | 8.50B | 8.75B | +3.0% |
| Q1 FY2026 | 9 Dec 2025 | 2.77 | 2.84 | +2.5% | 7.72B | 8.17B | +5.8% |
| Q4 FY2025 | 16 Sept 2025 | 3.01 | 3.48 | +15.6% | 8.40B | 8.50B | +1.2% |
| Q3 FY2025 | 3 Jun 2025 | 2.01 | 2.50 | +24.4% | 7.42B | 7.62B | +2.8% |
| Q2 FY2025 | 11 Mar 2025 | 1.58 | 1.52 | -3.8% | 6.77B | 6.87B | +1.5% |
| Q1 FY2025 | 10 Dec 2024 | 2.62 | 2.45 | -6.5% | 7.81B | 7.77B | -0.5% |
| Q4 FY2024 | 17 Sept 2024 | 2.85 | 2.98 | +4.6% | 8.01B | 7.95B | -0.8% |
| Q3 FY2024 | 4 Jun 2024 | 2.32 | 2.32 | 0.0% | 7.31B | 7.31B | 0.0% |
| Q2 FY2024 | 6 Mar 2024 | 1.84 | 1.74 | -5.4% | 6.72B | 6.67B | -0.8% |
Ferguson stock price 2027–2032: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Ferguson's earnings keep growing at the 8.2% a year analysts expect to FY2030, it would earn about 19.14 a share in FY2032. At the P/E it has traded at over the last five years (12.8 to 26.0) that is 245.66 to 498.46 a share, or 400.41 at its average P/E of 20.9. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 12.58 | 161.46 | 263.17 | 327.62 |
| FY2028 | 13.91 | 178.49 | 290.93 | 362.18 |
| FY2030 | 16.36 | 209.90 | 342.12 | 425.90 |
| FY2031 (extrapolated) | 17.69 | 227.07 | 370.12 | 460.75 |
| FY2032 (extrapolated) | 19.14 | 245.66 | 400.41 | 498.46 |
Each year's EPS is the analysts' consensus to FY2030; the years after grow 8.2% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (12.8, 20.9, 26.0).
Is Ferguson stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Ferguson's P/E of 24.1 is near the top of its 5-year range (10.3 to 29.7, median 19.8). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay more for each point of growth than usual: a PEG of 1.7 on expected growth against 1.2 on its median P/E and past five years' growth. At its usual P/E (19.8 × EPS of 10.65), Ferguson's fair value is 211.22; the price, 256.85, is 21.6% above it. Its forward P/E, on the consensus for FY2027, is 20.4.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (10.3 and 29.7). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 24.12
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 19.83
- Five-year P/E range
- 10.3 – 29.7
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 20.42
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 2.95
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +10.2%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 97.350 | 194.84146Price 97.35244 | +100.1% | |
| 119.980 | 236.63177Price 119.98296 | +97.2% | |
| 197.050 | 384.58163Price 197.052,644 | +95.2% | |
| 157.530 | 305.52161Price 157.53396 | +93.9% | |
| 43.270 | 82.9546Price 43.27165 | +91.7% | |
| 214.470 | 405.52304Price 214.47507 | +89.1% | |
| 163.700 | 308.95212Price 163.70442 | +88.7% |
Furthest below the fair value on each stock's page, updated every day.